Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: A meta-analysis of prospective studies

por Liu, Lin, Zheng, Ying-hui, Han, Li, Qin, Shu-Kui
Publicado 2016

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report

por Cheng, Yuan, Zhang, Juan, Qin, Shu kui, Hua, Hai qing
Publicado 2018

Type I neurofibromatosis with spindle cell sarcoma: A case report

por Zhang, Yu, Chao, Jiao-Jiao, Liu, Xiu-Feng, Qin, Shu-Kui
Publicado 2019

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells

por Wu, Qiong, Qin, Shu-Kui, Teng, Feng-Meng, Chen, Chang-Jie, Wang, Rui
Publicado 2010

A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib

por Yang, Yan, Qin, Shu-Kui, Zhu, Jian, Wang, Rui, Li, Yu-Mei, Xie, Zong-Yu, Wu, Qiong
Publicado 2017

Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, sin...

por Cheng, Yuan, Qin, Shu Kui, Chen, Yan Ping, Dong, Li Hua, Sun, Xiang Dong, Yu, Shi Ying, Wu, Shi Kai
Publicado 2018

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

por Tabernero, Josep, Bang, Yung-Jue, Van Cutsem, Eric, Fuchs, Charles S, Janjigian, Yelena Yuriy, Bhagia, Pooja, Li, Kan, Adelberg, David, Qin, Shu Kui
Publicado 2021

Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition

por YANG, YAN, QIN, SHU-KUI, WU, QIONG, WANG, ZI-SHU, ZHENG, RONG-SHENG, TONG, XU-HUI, LIU, HAO, TAO, LIANG, HE, XIAN-DI
Publicado 2014

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells

por Lu, Pei-Hua, Chen, Min-Bin, Liu, Yuan-Yuan, Wu, Mian-Hua, Li, Wen-Ting, Wei, Mu-Xin, Liu, Chao-Ying, Qin, Shu-Kui
Publicado 2017

Managing Pain in Patients With Cancer: The Chinese Good Pain Management Experience

por Yu, Shi-Ying, Wang, Jie-Jun, Huang, Yu-guang, Hu, Bing, Wang, Kun, Li, Ping Ping, Wu, Yi-Long, Zhang, He-Long, Zhang, Li, Zhang, Qing-Yuan, Qin, Shu-Kui
Publicado 2016

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2

por Finn, Richard S, Yau, Thomas, Hsu, Chih-Hung, De Toni, Enrico N, Goyal, Lipika, Galle, Peter R, Qin, ShuKui, Rao, Sujata, Sun, Fangfang, Wang, Chunxiao, Widau, Ryan C, Zhu, Andrew X
Publicado 2022

Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

por Qin, Shu‐Kui, Li, Qing, Ming Xu, Jian, Liang, Jun, Cheng, Ying, Fan, Ying, Jiang, Jun, Ye, Hao, Tao, Huimin, Li, Lian, Zheng, Limin, Wei, Zhaohui, Li, Shu, Meng, Kun, Ye, Bin, Sun, Yan
Publicado 2020

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811

por Chung, Hyun Cheol, Bang, Yung-Jue, S Fuchs, Charles, Qin, Shu-Kui, Satoh, Taroh, Shitara, Kohei, Tabernero, Josep, van Cutsem, Eric, Alsina, Maria, Cao, Zhu Alexander, Lu, Jia, Bhagia, Pooja, Shih, Chie-Schin, Janjigian, Yelena Y
Publicado 2020

A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma

por Zhang, Yang, Luo, Fan, Ma, Yu-Xiang, Liu, Qian-Wen, Yang, Yun-Peng, Fang, Wen-Feng, Huang, Yan, Zhou, Ting, Li, Jin, Pan, Hong-Ming, Yang, Lei, Qin, Shu-Kui, Zhao, Hong-Yun, Zhang, Li
Publicado 2022

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

por Guan, Zhong-Zhen, Xu, Jian-Ming, Luo, Rong-Cheng, Feng, Feng-Yi, Wang, Li-Wei, Shen, Lin, Yu, Shi-Ying, Ba, Yi, Liang, Jun, Wang, Dong, Qin, Shu-Kui, Wang, Jie-Jun, He, Jing, Qi, Chuan, Xu, Rui-Hua
Publicado 2011

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients...

por Chung, Hyun Cheol, Kang, Yoon‐Koo, Chen, Zhendong, Bai, Yuxian, Wan Ishak, Wan Zamaniah, Shim, Byoung Yong, Park, Young Lee, Koo, Dong‐Hoe, Lu, Jianwei, Xu, Jianming, Chon, Hong Jae, Bai, Li‐Yuan, Zeng, Shan, Yuan, Ying, Chen, Yen‐Yang, Gu, Kangsheng, Zhong, Wen Yan, Kuang, Shu, Shih, Chie‐Schin, Qin, Shu‐Kui
Publicado 2021